Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAIR study of adherence to glatiramer acetate and received care in relapsing-remitting multiple sclerosis
NL-OMON26562Recruiting
- Sponsor
- MS4 Research Institute
- Start
- Jul 2009
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of glatiramer acetate in multiple sclerosis (MS), sponsored by MS4 Research Institute. Primary endpoints: Number of missed doses, GA treatment discontinuation and 2 more. Started Jul 2009; status: recruiting.
02
Drugs
glatiramer acetate
03
Conditions
multiple sclerosis (MS)
Beyond the preview
Go deeper on NL-OMON26562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26562.